Found 5 matching trials
Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion PHASE2 The main purpose of this study is to explore the feasibility of selecting t...
Show More Location
Tianjin Medical Unversity Second Hospital
Learn More & Join Trial
A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive PHASE3 This study is an open-label, randomized, controlled, multicenter Phase IIIb...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC) PHASE2 This is a prospective, single-center phase II clinical study aimed at evalu...
Show More Location
Fudan University Shanghai Cancer Center, Shanghai,
Learn More & Join Trial
A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN). PHASE2 The goal of this clinical trial is to evaluate the safety and efficacy of P...
Show More Status
Active Not Recruiting
Location
Beijing Tiantan Hospital,Capital Medical University
Learn More & Join Trial
Vebreltinib Plus PLB1004 Versus Platinum-based Doublet Chemotherapy in Patients With EGFRm, MET+, Locally Advanced or Metastatic NSCLC Following EGFR-TKI Failure PHASE3 Efficacy and Safety of Vebreltinib in Combination With PLB1004 Versus Plati...
Show More Location
Multiple Locations
Learn More & Join Trial